Cargando…
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
Interstitial lung diseases represent a heterogeneous and wide group of diseases in which factors leading to disease initiation and progression are not fully understood. Recent evidence suggests that the lung microbiome might influence the pathogenesis and progression of interstitial lung diseases. I...
Autores principales: | Amati, Francesco, Stainer, Anna, Mantero, Marco, Gramegna, Andrea, Simonetta, Edoardo, Suigo, Giulia, Voza, Antonio, Nambiar, Anoop M., Cariboni, Umberto, Oldham, Justin, Molyneaux, Philip L., Spagnolo, Paolo, Blasi, Francesco, Aliberti, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779068/ https://www.ncbi.nlm.nih.gov/pubmed/35055163 http://dx.doi.org/10.3390/ijms23020977 |
Ejemplares similares
-
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review
por: Amati, Francesco, et al.
Publicado: (2023) -
Walking the path of treatable traits in interstitial lung diseases
por: Amati, Francesco, et al.
Publicado: (2023) -
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia
por: Amati, Francesco, et al.
Publicado: (2023) -
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity
por: Blasi, Francesco, et al.
Publicado: (2021) -
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis
por: Suska, Kseniia, et al.
Publicado: (2022)